About the cover
Free online issue
2009 Abstract Supplement
Volume 86, No 1
July 2009
ISSN: 0009-9236
EISSN: 1532-6535
Impact Factor 7.586*
Rank: 9/216 Pharmacology and Pharmacy
Editor-in-Chief:
Scott Waldman, MD, PhD, FCP
*2008 Journal Citation Report (Thomson Reuters, 2009)
FEATURED ARTICLES
IN THIS ISSUE
In This Issue FREEMACROSCOPY
Biomarkers in drug development FREEPOINT/COUNTERPOINT
Retail genomics: a risky public resource FREESTATE OF THE ART
Ensuring the future success of SEPs by examining their past failures FREEARTICLES
Environmental vs. inherited factors that contribute to drug response FREETRANSLATIONAL MEDICINE
Advancing cancer treatment options with I-SPY 2 FREENews and Views
A new article from Nature Reviews Drug Discovery reviews methods of chemoprevention, and explores why its utilization remains limited. Read the full review.
Encouraging results have been found in the first phase 2 gene therapy trial for HIV-1. Infected adults receiving an anti-HIV ribozyme had significantly higher CD4+ lymphocyte counts. Read the article from Nature Medicine.
In the press
To avoid unpredictable pharmacological responses among adolescents, this population should be more actively recruited into clinical trials, according to a new Commentary in Clinical Pharmacology & Therapeutics. Read the article and the press release.
Nature Medicine reports a possible link between epileptic seizures and an interaction between immune cells and brain blood vessels. These interactions might be a target for the prevention and treatment of epilepsy. Read the article and the press release.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
